Krunal Industries Private Limited is poised to revolutionize the pharmaceutical industry with its upcoming Pharma Intermediates Unit Project in Manjusar, Vadodara, Gujarat. This ambitious venture underscores the company's commitment to innovation and excellence in the production of pharmaceutical intermediates. With a projected capacity of 4100 tons per month, the facility is primed to meet the growing demand for high-quality intermediates, catering to both domestic and international markets.
Situated in the industrial hub of Manjusar, Vadodara, Gujarat, the project enjoys strategic advantages in terms of access to skilled labor, infrastructure, and transportation networks. This favorable location not only enhances operational efficiency but also facilitates seamless distribution and logistics, enabling Krunal Industries Private Limited to deliver its products with speed and reliability.
The Pharma Intermediates Unit Project represents a significant investment, with an infusion of 5 crores earmarked for its development. This substantial financial commitment underscores the company's confidence in the project's potential to drive growth and profitability. By leveraging modern manufacturing techniques and adhering to stringent quality standards, Krunal Industries aims to establish itself as a trusted supplier of pharmaceutical intermediates, fostering long-term partnerships with clients worldwide.
News by Rahul Yelligetti